A study has found that drugs with high abuse potential are around six times more likely to be approved as compared to drugs with low abuse potential for pain medications.
“The probability of successful development programs was 27.8 percent for high abuse potential compounds and 4.7 percent for low abuse potential compounds,” the authors wrote in the study. New studies on potentially addictive pain medications have reduced since the peak of the opioid epidemic in 2010. Drugs with higher likelihood of abuse are still more likely to pass clinical trials and get approved, compared to drugs with low likelihood of drug abuse, according to the study….